Protozoa are single-celled eukaryotic organisms that exist either as free-living entities or as parasites. In medical microbiology, understanding these microscopic life forms is essential because several species cause severe human diseases. Unlike bacteria, protozoa possess a defined nucleus and membrane-bound organelles, making their cellular structure more complex. They reproduce primarily through asexual division, though some species also utilize sexual cycles.
In the context of tropical nursing and midwifery in Nigeria, blood and tissue protozoa demand constant vigilance. Transmission typically occurs through insect vectors, contaminated water, or direct contact. Recognizing how these parasites invade human hosts forms the foundation for effective clinical assessment and management.
The genus Plasmodium includes multiple species, but only five are traditionally recognized as responsible for human malaria. Identifying the specific species is clinically relevant because each exhibits distinct biological behaviors and potential for disease severity.
The life cycle of Plasmodium alternates between a human intermediate host and a female *Anopheles* mosquito definitive host. Understanding this cycle clarifies why vector control and medication timing work together.
Once Plasmodium falciparum infects red blood cells, profound physiological changes occur. The infected erythrocytes undergo structural modifications, developing surface knobs that cause them to stick to the endothelial lining of small blood vessels—a process known as cytoadherence.
This sequestration prevents the parasitized cells from circulating through the spleen where they would normally be filtered out. Consequently, microvascular beds in vital organs like the brain, placenta, and kidneys become blocked, leading to localized tissue hypoxia, ischemia, and metabolic acidosis. Furthermore, systemic inflammation driven by tumor necrosis factor and other cytokines amplifies the clinical severity, resulting in multi-organ dysfunction if treatment is delayed.
Malaria in pregnancy presents unique diagnostic and clinical challenges. During gestation, a woman experiences natural immunomodulation that increases her susceptibility to Plasmodium falciparum infection, often rendering her less able to control parasite density even with prior acquired immunity.
A pregnant woman may present with classic symptoms such as intermittent fever, chills, headache, and generalized malaise. However, infection frequently leads to placental malaria, where parasites accumulate in the intervillous spaces without causing dramatic peripheral blood symptoms. Consequently, a pregnant patient might harbor heavy placental parasitemia while showing minimal or atypical symptoms, making routine screening at antenatal clinics indispensable.
Accurate and prompt diagnosis remains the cornerstone of effective malaria case management. Midwives and clinical staff rely on two primary methods in daily practice:
Clinical diagnosis based on symptoms alone is discouraged because malaria signs mimic many other febrile illnesses common in Nigeria, such as typhoid fever and urinary tract infections.
Managing malaria during pregnancy requires balancing effective parasite clearance with fetal safety. Uncomplicated falciparum malaria in the first trimester is treated with safe alternatives like oral quinine, whereas Artemisinin-based Combination Therapies are recommended during the second and third trimesters.
To prevent the devastating consequences of malaria in pregnancy, the World Health Organization and Nigerian national guidelines recommend Intermittent Preventive Treatment in pregnancy (IPTp). This involves administering a full treatment course of Sulfadoxine-Pyrimethamine (SP) at routine antenatal care visits, starting early in the second trimester and continuing at least one month apart until delivery. IPTp significantly reduces maternal anemia, placental parasitemia, and low birth weight.
When left untreated or poorly managed, malaria during pregnancy inflicts severe morbidity and mortality on both mother and baby. The sequestration of parasites in the placenta disrupts nutrient and oxygen exchange, leading to fetal growth restriction, low birth weight, premature delivery, and stillbirth.
For the mother, persistent hemolysis and bone marrow suppression frequently precipitate severe maternal anemia, which increases the risk of postpartum hemorrhage and maternal death. In severe cases, patients may develop cerebral malaria, pulmonary edema, or acute kidney injury. Midwives must remain vigilant for subtle warning signs to ensure immediate escalation and emergency medical intervention.